2009 SCAI Scientific Sessions Schedule

Jump to navigation Jump to search

Here is the page we will use to coordinate filming at SCAI 2009

Filming will occur from Wednesday to Friday (May 6 - May 8).


Click on Date for Detailed Schedule

Wednesday, May 6, 2009

Thursday, May 7, 2009

Friday, May 8, 2009

Wednesday, May 6, 2009

11:30 AM

  • Event: Press conference
  • Location: Pompeian Ballroom
  • Trial/topic: Late-Breaking Clinical Trial: The Clopidogrel Medco Outcomes Study on the possible effects of clopidogrel and heart burn medications known as PPIs
  • Presenter:

1:00 PM

  • Event: Concurrent Session II- Current DES: What's Different? What's the Same?
  • Location:
  • Trial/topic: DES in 2009: State of the Art Review
  • Presenter: David Cohen, MD

1:15 PM

  • Event: Concurrent Session II- Current DES: What's Different? What's the Same?
  • Location:
  • Trial/topic: Currently Approved Drug-Eluting Stents: Are There Meaningful Differences?
  • Presenter: Donald E. Cutlip, MD, FSCAI

1:30 PM

  • Event: Concurrent Session II- Current DES: What's Different? What's the Same?
  • Location:
  • Trial/topic: DES Marinade: Optimal Pharmacology
  • Presenter: Matthew J. Price, MD

1:45 PM

  • Event: Concurrent Session II- Current DES: What's Different? What's the Same?
  • Location:
  • Trial/topic: Long Term DES Results: Pathologic Lessons
  • Presenter: Renu Vermani, MD

2:00 PM

  • Event: Concurrent Session II- Current DES: What's Different? What's the Same?
  • Location:
  • Trial/topic: Stent Thrombosis: Predictors and Prevention
  • Presenter:

2:15 PM

  • Event: Concurrent Session II- Current DES: What's Different? What's the Same?
  • Location:
  • Trial/topic: Role of Bare Metal Stents in Contemporary Practice
  • Presenter: Spencer B. King, III, MD, FSCAI

2:30 PM

  • Event: Concurrent Session II- Current DES: What's Different? What's the Same?
  • Location:
  • Trial/topic: Managing the DES Patient Having Non-Cardiac Surgery
  • Presenter: Timothy A. Sanborn, MD, FSCAI

3:30 PM

  • Event: Concurrent Session II- Emerging Tech: Stent Pipeline
  • Location:
  • Trial/topic: The Next Wave of Workhorse Drug-Eluting Stents
  • Presenter:

3:45 PM

  • Event: Concurrent Session II- Emerging Tech: Stent Pipeline
  • Location:
  • Trial/topic: Niche Stents: Bifurcation, ostial and Small Vessels/Long Lesions
  • Presenter: Aaron V. Kaplan, MD, FSCAI

4:00 PM

  • Event: Concurrent Session II- Emerging Tech: Stent Pipeline
  • Location:
  • Trial/topic: Strategies to Enhance Endothelial Healing
  • Presenter: Roxana Mehran, MD, FSCAI

4:15 PM

  • Event: Concurrent Session II- Emerging Tech: Stent Pipeline
  • Location:
  • Trial/topic: Beyond Permanent Polymers: Novel Drug Delivery Platforms
  • Presenter: Alexander Abizaid, MD

4:30 PM

  • Event: Concurrent Session II- Emerging Tech: Stent Pipeline
  • Location:
  • Trial/topic: Why have a Permanent Implant: The Bioresorbable Alternative
  • Presenter: Ron Waksman, MD

4:45 PM

  • Event: Concurrent Session II- Emerging Tech: Stent Pipeline
  • Location:
  • Trial/topic: The Road to Approval of Novel Drug-Eluting Stent Devices
  • Presenter: Ashley B Boam

Return to top

Thursday, May 7, 2009

8:00 AM

  • Event: Concurrent Session I- PCI: Antithrombotic Therapy
  • Location:
  • Trial/topic: Pharmacology and Mechanisms of Anti-Thrombin Therapy
  • Presenter: Sunil Rao, MD, FSCAI

8:15 AM

  • Event: Concurrent Session I- PCI: Antithrombotic Therapy
  • Location:
  • Trial/topic: Optimal Upstream Anti-Thrombin Therapy
  • Presenter: E. Magnus Ohman, MD, FSCAI

8:30 AM

  • Event: Concurrent Session I- PCI: Antithrombotic Therapy
  • Location:
  • Trial/topic: Why Heparin Still Has a Role in Contemporary PCI
  • Presenter: James P. Zidar, MD, FSCAI

8:45 AM

  • Event: Concurrent Session I- PCI: Antithrombotic Therapy
  • Location:
  • Trial/topic: Bivalrudin: Should it Be the Agent of Choice for All PCI's?
  • Presenter: Frederick Feit, MD

9:00 AM

  • Event: Concurrent Session I- PCI: Antithrombotic Therapy
  • Location:
  • Trial/topic: New Anti-Thrombotic Agents on the Horizon
  • Presenter: Neal S. Kleiman, MD, FSCAI
  • Event: Press conference
  • Location: Pompeian Ballroom
  • Trial/topic: Late-Breaking Clinical Trials: Zilver trial of the first drug-eluting stent for peripheral artery disease and AMADEUS trial on percutaneous mitral valve repair. New expert consensus paper on length of stay following elective percutaneous coronary intervention (PCI)
  • Presenter:

9:15 AM

  • Event: Concurrent Session I- PCI: Antithrombotic Therapy
  • Location:
  • Trial/topic: The Impact of Bleeding on PCI Outcomes
  • Presenter: Steven V. Manoukian, MD, FSCAI

10:15 AM

  • Event: Concurrent Session I- PCI: Antiplatelet Therapy
  • Location:
  • Trial/topic: TRITON: Summary, With New Unpublished Data
  • Presenter: Theodore A. Bass, MD, FSCAI

10:30 AM

  • Event: Concurrent Session I- PCI: Antiplatelet Therapy
  • Location:
  • Trial/topic: How I Believe Cardiologist Should (and Should Not) Integrate Prasugrel into Practice
  • Presenter: Stephen G. Ellis, MD

10:45 AM

  • Event: Concurrent Session I- PCI: Antiplatelet Therapy
  • Location:
  • Trial/topic: High Platelet Reactivity: What, if Anything, Does it Mean?
  • Presenter: Steven R. Steinhubl, MD

11:00 AM

  • Event: Concurrent Session I- PCI: Antiplatelet Therapy
  • Location:
  • Trial/topic: AZD 6140: Summary of What We Know and Can Expect
  • Presenter: Peter B. Berger, MD, FSCAI

11:15 AM

  • Event: Concurrent Session I- PCI: Antiplatelet Therapy
  • Location:
  • Trial/topic: Cangrelor: Summary, and My View of its Future Role
  • Presenter: John J. Young, MD, FSCAI

1:15 PM

  • Event: Concurrent Session I- PCI: Chronic Total Occlusions
  • Location:
  • Trial/topic: Clinical Rationale of Recanalization of CTO
  • Presenter: James R. Margolis, MD

1:30 PM

  • Event: Concurrent Session I- PCI: Chronic Total Occlusions
  • Location:
  • Trial/topic: Role of Pre-Procedural Imaging for CTO
  • Presenter: Bradley H. Strauss, MD

1:45 PM

  • Event: Concurrent Session I- PCI: Chronic Total Occlusions
  • Location:
  • Trial/topic: New Antegrade Strategy: Recanalization of Invisible Micro-Channel
  • Presenter: Gerald Werner, MD

2:00 PM

  • Event: Concurrent Session I- PCI: Chronic Total Occlusions
  • Location:
  • Trial/topic: IVUS Guidance for CTO Recanalization
  • Presenter: David Kandzari, MD, FSCAI

2:15 PM

  • Event: Concurrent Session I- PCI: Chronic Total Occlusions
  • Location:
  • Trial/topic: Retrograde Approach: US Experience
  • Presenter: Craig A. Thompson, MD, FSCAI

2:30 PM

  • Event: Concurrent Session I- PCI: Chronic Total Occlusions
  • Location:
  • Trial/topic: Retrograde Approach: European Experience
  • Presenter: Alfredo R. Galassi, MD, FSCAI

2:45 PM

  • Event: Concurrent Session I- PCI: Chronic Total Occlusions
  • Location:
  • Trial/topic: Updated Retrograde Approach from Japan
  • Presenter: Etuso Tsuchikane, MD, FSCAI

3:00 PM

  • Event: Concurrent Session I- PCI: Chronic Total Occlusions
  • Location:
  • Trial/topic: New Technology for CTO Revascularization
  • Presenter: William L. Lombardi, MD, FSCAI

3:45 PM

  • Event: Concurrent Session I- Debates
  • Location:
  • Trial/topic: Is COURAGE Still Relevant?
  • Presenter: Matthew R. Wolff, MD, FSCAI and Frederick Feit, MD, FSCAI

4:15 PM

  • Event: Concurrent Session I- Debates
  • Location:
  • Trial/topic: Elective PCI without Onsite Surgery is the New Standard of Care
  • Presenter: Michael A. Kutcher, MD, FSCAI and Gregory J. Dehmer, MD, FSCAI

4:45 PM

  • Event: Concurrent Session I- Debates
  • Location:
  • Trial/topic: PCI Should Replace CABG in Most Patients with Multi Vessel Disease
  • Presenter: Antonio Colombo, MD, FSCAI and David R. Holmes, Jr., MD, FSCAI

6:00 PM

  • Event: Interviews for Women in Innovations
  • Location: Tiberius V room of Caesar’s Palace

7:00 PM

  • Topic: Women in Innovations dinner conference
  • Location: Tiberius V room of Caesar’s Palace
  • Presenter: Roxana Mehran
  • Contact: Rebecca Teichgraeber, Associate Director, Education, SCAI, 2400 N St NW, Ste 500, Washington, DC 20037. Direct line: 202.741.9872, Cell:202 360 9962, rebeccat@scai.org

Return to top

Friday, May 8, 2009

8:00 AM

  • Event: Concurrent Session I- What Do We Do Now?
  • Location:
  • Trial/topic: Ideal Systems of Care for Managing STEMI (Outside of Minnesota)
  • Presenter: Timothy D. Henry, MD, FSCAI

8:15 AM

  • Event: Concurrent Session I- What Do We Do Now?
  • Location:
  • Trial/topic: Optimum Pharmacologic Management with Primary PCI for STEMI: How Does HORIZONS Change the Paradigm?
  • Presenter: Gregg W. Stone, MD, FSCAI

8:30 AM

  • Event: Concurrent Session I- What Do We Do Now?
  • Location:
  • Trial/topic: Large Thrombus Burden with STEMI: What Should We Do Now?
  • Presenter: David A. Cox, MD, FSCAI

8:45 AM

  • Event: Concurrent Session I- What Do We Do Now?
  • Location:
  • Trial/topic: Reducing Infarct Size with Primary PCI for STEMI: Can We Find the Holy Grail?
  • Presenter:

9:00 AM

  • Event: Concurrent Session I- What Do We Do Now?
  • Location:
  • Trial/topic: Drug-Eluting versus Bare Metal Stents for STEMI- Does HORIZONS Provide the Answers?
  • Presenter: Peter Casterella, MD

9:15 AM

  • Event: Concurrent Session I- What Do We Do Now?
  • Location:
  • Trial/topic: New Systems of Care for Management of STEMI: Implications for Reimbursement
  • Presenter: Peter Casterella, MD

10:15 AM

  • Event: Main Session- Emerging Therapy: Antiplatelet Drugs
  • Location:
  • Trial/topic: Platelet Physiology and Blockade for Interventionalist
  • Presenter:
  • Event: Concurrent Session I- PCI: Guideline Update
  • Location:
  • Trial/topic: Early Invasive Strategy in UA/NSTEMI: In Whom and When?
  • Presenter: William Boden, MD

10:30 AM

  • Event: Main Session- Emerging Therapy: Antiplatelet Drugs
  • Location:
  • Trial/topic: Do We Need New Antiplatelet Agents?
  • Presenter: C. Michael Gibson, MD
  • Event: Concurrent Session I- PCI: Guideline Update
  • Location:
  • Trial/topic: Facilitated PCI: Is the Issue Closed?
  • Presenter: Stephen G. Ellis, MD

10:45 AM

  • Event: Main Session- Emerging Therapy: Antiplatelet Drugs
  • Location:
  • Trial/topic: Prasugrel
  • Presenter: Dave Morrow, MD
  • Event: Concurrent Session I- PCI: Guideline Update
  • Location:
  • Trial/topic: Pharmaco-Invasive Strategy in STEMI: When and Where?
  • Presenter: Eric R. Bates, MD

11:00 AM

  • Event: Main Session- Emerging Therapy: Antiplatelet Drugs
  • Location:
  • Trial/topic: Reversible P2Y12 Inhibitors
  • Presenter: Theodore A. Bass, MD, FSCAI
  • Event: Concurrent Session I- PCI: Guideline Update
  • Location:
  • Trial/topic: Antiplatelet Therapy: Issues and Concerns
  • Presenter: E. Magnus Ohman, MD, FSCAI

11:15 AM

  • Event: Main Session- Emerging Therapy: Antiplatelet Drugs
  • Location:
  • Trial/topic: Thrombin Receptor Antagonists
  • Presenter:
  • Event: Concurrent Session I- PCI: Guideline Update
  • Location:
  • Trial/topic: Anticoagulant Therapy: Which Agent?
  • Presenter: Sunil Rao, MD, FSCAI

11:30 AM

  • Event: Main Session- Emerging Therapy: Antiplatelet Drugs
  • Location:
  • Trial/topic: Measuring Platelet Reactivity in the Individual Patient: Is it Ready for Prime Time?
  • Presenter: Paul A. Gurble, MD
  • Event: Concurrent Session I- PCI: Guideline Update
  • Location:
  • Trial/topic: Selection of BMS vs DES in Clinical Practice
  • Presenter: William D. Knopf, MD, FSCAI

1:15 PM

  • Event: Concurrent Session I- PCI v. Medicine v. CABG
  • Location:
  • Trial/topic: Who Gets PCI in Current Practice? A Report from the NCDR
  • Presenter: Ralph G. Brindis, MD, FSCAI

1:30 PM

  • Event: Concurrent Session I- PCI v. Medicine v. CABG
  • Location:
  • Trial/topic: Medical Therapy after COURAGE and SYNTAX
  • Presenter: William Boden, MD

1:45 PM

  • Event: Concurrent Session I- PCI v. Medicine v. CABG
  • Location:
  • Trial/topic: Treatment Strategies for CAD: Are We Getting What We Pay For?
  • Presenter: William Weintraub, MD

2:00 PM

  • Event: Concurrent Session I- PCI v. Medicine v. CABG
  • Location:
  • Trial/topic: PCI vs CABG: Registry Data
  • Presenter: William Hui, MbC

2:15 PM

  • Event: Concurrent Session I- PCI v. Medicine v. CABG
  • Location:
  • Trial/topic: PCI vs CABG Meta-Analysis
  • Presenter: Mark A. Hlatky, MD

2:30 PM

  • Event: Concurrent Session I- PCI v. Medicine v. CABG
  • Location:
  • Trial/topic: Workforce of the Near Future: Do We Need More or Fewer Interventionalists to Treat CAD Over the Next Decade?
  • Presenter: Bonnie H. Weiner, MD, FSCAI

2:45 PM

  • Event: Main Session- Practice Changing Trials and Abstracts- STEMI
  • Location:
  • Trial/topic: Facilitated PCI Dead or Alive
  • Presenter: Timothy D. Henry, MD, FSCAI
  • Event: Concurrent Session I- PCI v. Medicine v. CABG
  • Location:
  • Trial/topic: PCI vs Medicine vs CABG Perspective
  • Presenter: Spencer B. King III, MD, FSCAI

2:55 PM

  • Event: Main Session- Practice Changing Trials and Abstracts- STEMI
  • Location:
  • Trial/topic: Anti-Coagulation Strategies During STEMI PCI
  • Presenter: Roxana Mehran, MD, FSCAI

3:05 PM

  • Event: Main Session- Practice Changing Trials and Abstracts- STEMI
  • Location:
  • Trial/topic: DES v BMS
  • Presenter: John S. Douglas, MD, FSCAI

3:45 PM

  • Event: Concurrent Session I: Debates
  • Location:
  • Trial/topic: Facilitated PCI Has a Place?
  • Presenter: Timothy D. Henry, MD, FSCAI and David A. Cox, MD, FSCAI

4:15 PM

  • Event: Concurrent Session I: Debates
  • Location:
  • Trial/topic: IIb/IIIa's are Passe
  • Presenter: Roxana Mehran, MD, FSCAI and Samin K. Sharma, MD, FSCAI

4:45 PM

  • Event: Concurrent Session I: Debates
  • Location:
  • Trial/topic: Thrombectomy is a Must for STEMI
  • Presenter: Mark A. Turco, MD, FSCAI and Harry R. Phillips, MD, FSCAI

Return to top

Retrieved from "https://www.wikidoc.org/index.php?title=2009_SCAI_Scientific_Sessions_Schedule&oldid=543133"